Immunodiagnosis of human leptospirosis using saliva

Area of Science:

• Medical Diagnostics
• Infectious Diseases
• Immunology

Background:

• Leptospirosis is a significant zoonotic disease globally.
• Accurate and accessible diagnostic methods are crucial for effective disease management and surveillance.
• Current diagnostics often rely on serum samples, which can be invasive.

Purpose of the Study:

• To evaluate the efficacy of enzyme-linked immunosorbent assay (ELISA) using saliva for detecting immunoglobulin M (IgM) antibodies in leptospirosis patients.
• To compare the diagnostic performance of saliva-based testing with traditional serum-based testing.
• To assess the potential of saliva as a non-invasive alternative for leptospirosis diagnosis and epidemiological studies.

Main Methods:

• Paired saliva and serum samples were collected from 40 patients diagnosed with leptospirosis.
• Samples were tested using an enzyme-linked immunosorbent assay (ELISA) specific for immunoglobulin M (IgM) class antibodies.
• A control group of 60 healthy individuals provided saliva and serum samples to establish baseline negativity.

Main Results:

• The ELISA detected specific IgM antibodies in 87.5% of saliva samples from leptospirosis patients.
• Serum samples from the same patients showed a 100% positivity rate for specific IgM antibodies.
• No positive results were observed in saliva or serum samples from the 60 control individuals, indicating high specificity.

Conclusions:

• Saliva can be a viable alternative to serum for the diagnosis of human leptospirosis using ELISA.
• The high sensitivity and specificity observed suggest saliva testing is suitable for both clinical diagnosis and large-scale epidemiological surveys.
• Further research can explore saliva diagnostics for other infectious diseases.